{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T15:37:43Z","timestamp":1794325063182,"version":"4.9.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"9689","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/s0140-6736(09)61343-x","type":"journal-article","created":{"date-parts":[[2009,8,14]],"date-time":"2009-08-14T05:29:47Z","timestamp":1250227787000},"page":"534-542","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1946,"title":["Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial"],"prefix":"10.1016","volume":"374","clinical-trial-number":[{"clinical-trial-number":"nct00129545","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"David R","family":"Holmes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek Y","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoltan G","family":"Turi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shephal K","family":"Doshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horst","family":"Sievert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice","family":"Buchbinder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M","family":"Mullin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Sick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S0140-6736(09)61343-X_bib1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1161\/CIRCULATIONAHA.105.595140","article-title":"Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980\u20132000, and implications on the projections for future prevalence","volume":"114","author":"Miyasaka","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/S0140-6736(09)61343-X_bib2","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1001\/jama.1994.03510350050036","article-title":"Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham Heart Study","volume":"271","author":"Benjamin","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/S0140-6736(09)61343-X_bib3","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1161\/01.CIR.96.7.2455","article-title":"Incidence of and risk factors for atrial fibrillation in older adults","volume":"96","author":"Psaty","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/S0140-6736(09)61343-X_bib4","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1136\/heart.86.5.516","article-title":"Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew\/Paisley study","volume":"86","author":"Stewart","year":"2001","journal-title":"Heart"},{"key":"10.1016\/S0140-6736(09)61343-X_bib5","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0895-4356(01)00478-4","article-title":"Incidence of chronic atrial fibrillation in general practice and its treatment pattern","volume":"55","author":"Ruigomez","year":"2002","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/S0140-6736(09)61343-X_bib6","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1161\/01.CIR.0000140263.20897.42","article-title":"Lifetime risk for development of atrial fibrillation: the Framingham Heart Study","volume":"110","author":"Lloyd-Jones","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/S0140-6736(09)61343-X_bib7","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham Study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"},{"key":"10.1016\/S0140-6736(09)61343-X_bib8","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1161\/01.STR.27.10.1760","article-title":"Stroke severity in atrial fibrillation. The Framingham Study","volume":"27","author":"Lin","year":"1996","journal-title":"Stroke"},{"key":"10.1016\/S0140-6736(09)61343-X_bib9","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ccl.2007.12.011","article-title":"Reducing the risk for stroke in patients who have atrial fibrillation","volume":"26","author":"Garcia","year":"2008","journal-title":"Cardiol Clinic"},{"key":"10.1016\/S0140-6736(09)61343-X_bib10","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1001\/archinte.165.10.1185","article-title":"Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) study","volume":"165","author":"Sherman","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/S0140-6736(09)61343-X_bib11","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1056\/NEJMoa021328","article-title":"A comparison of rate control and rhythm control in patients with atrial fibrillation","volume":"347","author":"Wyse","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(09)61343-X_bib12","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa021375","article-title":"A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation","volume":"347","author":"Van Gelder","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(09)61343-X_bib13","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1161\/01.STR.0000254719.26536.a9","article-title":"Stroke prevention in atrial fibrillation pharmacologic rate versus rhythm control","volume":"38","author":"Sherman","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/S0140-6736(09)61343-X_bib14","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM199507063330102","article-title":"Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia","volume":"333","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(09)61343-X_bib15","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1056\/NEJM199011293232201","article-title":"The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation","volume":"323","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(09)61343-X_bib16","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1161\/01.CIR.84.2.527","article-title":"Stroke Prevention in Atrial Fibrillation study. Final results","volume":"84","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/S0140-6736(09)61343-X_bib17","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0735-1097(91)90585-W","article-title":"Canadian Atrial Fibrillation Anticoagulation (CAFA) study","volume":"18","author":"Connolly","year":"1991","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S0140-6736(09)61343-X_bib18","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJM199211123272002","article-title":"Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators","volume":"327","author":"Ezekowitz","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(09)61343-X_bib19","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0140-6736(89)91200-2","article-title":"Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study","volume":"1","author":"Petersen","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(09)61343-X_bib20","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/S0140-6736(09)61343-X_bib21","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1001\/jama.290.20.2685","article-title":"Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?","volume":"290","author":"Go","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/S0140-6736(09)61343-X_bib22","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1161\/01.STR.31.4.822","article-title":"Adverse outcomes and predictors of underuse of antithrombotic therapy in Medicare beneficiaries with chronic atrial fibrillation","volume":"31","author":"Gage","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/S0140-6736(09)61343-X_bib23","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.hrthm.2008.07.014","article-title":"Epidemiology and outcomes in patients with atrial fibrillation in the United States","volume":"5","author":"Walker","year":"2008","journal-title":"Heart Rhythm"},{"key":"10.1016\/S0140-6736(09)61343-X_bib24","doi-asserted-by":"crossref","first-page":"927","DOI":"10.7326\/0003-4819-131-12-199912210-00004","article-title":"Warfarin use among ambulatory patients with non valvular atrial fibrillation: the coagulation and risk factors in atrial fibrillation (ATRIA) study","volume":"131","author":"Go","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/S0140-6736(09)61343-X_bib25","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(06)68845-4","article-title":"Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events (ACTIVE W): a randomised controlled trial","volume":"367","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(09)61343-X_bib26","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1001\/jama.293.6.690","article-title":"Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial","volume":"293","author":"Albers","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/S0140-6736(09)61343-X_bib27","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/S0140-6736(03)14841-6","article-title":"Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial","volume":"362","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(09)61343-X_bib28","first-page":"S462","article-title":"Stroke prevention in atrial fibrillation: pooled analysis of SPORTIF III and V trials","volume":"10","author":"Albers","year":"2004","journal-title":"Am J Manag Care"},{"key":"10.1016\/S0140-6736(09)61343-X_bib29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1024\/0301-1526.38.1.13","article-title":"New anticoagulants\u2014towards the development of an \u201cideal\u201d anticoagulant","volume":"38","author":"Haas","year":"2009","journal-title":"Vasa"},{"key":"10.1016\/S0140-6736(09)61343-X_bib30","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0003-4975(95)00887-X","article-title":"Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation","volume":"61","author":"Blackshear","year":"1996","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/S0140-6736(09)61343-X_bib31","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.0954-6820.1969.tb07351.x","article-title":"Atrial fibrillation: a study of atrial thrombus and systemic embolism in a necropsy material","volume":"185","author":"Alberg","year":"1969","journal-title":"Acta Med Scand"},{"key":"10.1016\/S0140-6736(09)61343-X_bib32","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/0735-1097(94)00396-8","article-title":"Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: a transesophageal echocardiographic study","volume":"25","author":"Stoddard","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S0140-6736(09)61343-X_bib33","first-page":"9","article-title":"Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high risk patients with non rheumatic atrial fibrillation: results from the international multi-center feasibility trials","volume":"46","author":"Ostermayer","year":"2005","journal-title":"J Am Card Coll Cardiol"},{"key":"10.1016\/S0140-6736(09)61343-X_bib34","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1161\/01.CIR.0000015698.54752.6D","article-title":"Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation\u2014early clinical experience","volume":"105","author":"Sievert","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/S0140-6736(09)61343-X_bib35","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/j.jacc.2003.12.050","article-title":"Left atrial structure and function after percutaneous left atrial appendage transcatheter occlusion (PLAATO) six-month echocardiographic follow-up","volume":"43","author":"Hanna","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S0140-6736(09)61343-X_bib36","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.ahj.2006.02.005","article-title":"The PROTECT AF (WATCHMAN Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial","volume":"151","author":"Fountain","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/S0140-6736(09)61343-X_bib37","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.jacc.2007.02.035","article-title":"Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation","volume":"49","author":"Sick","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S0140-6736(09)61343-X_bib38","first-page":"704","article-title":"Clinical outcomes three years after PLAATO implantation","volume":"69","author":"El-Chami","year":"2007","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/S0140-6736(09)61343-X_bib39","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke. Results for the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/S0140-6736(09)61343-X_bib40","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1056\/NEJMoa011503","article-title":"Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both","volume":"345","author":"Mas","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(09)61343-X_bib41","series-title":"Bayesian data analysis","author":"Gelman","year":"1995"},{"key":"10.1016\/S0140-6736(09)61343-X_bib42","first-page":"687","article-title":"Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study","volume":"343","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(09)61343-X_bib43","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S1052-3057(97)80217-0","article-title":"The stroke prevention in atrial fibrillation III study: rationale, design, and patient features","volume":"6","year":"1997","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/S0140-6736(09)61343-X_bib44","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1055\/s-0038-1651587","article-title":"A method to determine the optimal intensity of oral anticoagulant therapy","volume":"69","author":"Rosendaal","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1016\/S0140-6736(09)61343-X_bib45","first-page":"667","article-title":"Left atrial appendage exclusion system for stroke prevention in atrial fibrillation: a percutaneous device delivery approach","volume":"56","author":"Lerakis","year":"2008","journal-title":"Minerva Cardioangiol"},{"key":"10.1016\/S0140-6736(09)61343-X_bib46","first-page":"553","article-title":"Mechanisms underlying air aspiration in patients undergoing left atrial catheterization","volume":"71","author":"Franzen","year":"2008","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/S0140-6736(09)61343-X_bib47","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa070829","article-title":"Optimal medical therapy with or without PCI for stable coronary disease","volume":"356","author":"Boden","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(09)61343-X_bib48","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1540-8175.2007.00369.x","article-title":"Implantation of left atrial appendage occlusion devices and complex appendage anatomy: the importance of transesophageal echocardiography","volume":"24","author":"Jorgenson","year":"2007","journal-title":"Echocardiography"},{"key":"10.1016\/S0140-6736(09)61343-X_bib49","doi-asserted-by":"crossref","first-page":"204S","DOI":"10.1378\/chest.126.3_suppl.204S","article-title":"The pharmacology and management of the vitamin K antagonists","volume":"126","author":"Ansell","year":"2004","journal-title":"Chest"},{"key":"10.1016\/S0140-6736(09)61343-X_bib50","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1161\/CIRCULATIONAHA.107.695163","article-title":"Challenges of establishing new antithrombotic therapies in atrial fibrillation","volume":"116","author":"Connolly","year":"2007","journal-title":"Circulation"}],"updated-by":[{"DOI":"10.1016\/s0140-6736(09)61953-x","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2009,11,7]],"date-time":"2009-11-07T00:00:00Z","timestamp":1257552000000}}],"container-title":["The Lancet"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014067360961343X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014067360961343X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T23:57:49Z","timestamp":1758844669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014067360961343X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":50,"journal-issue":{"issue":"9689","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S014067360961343X"],"URL":"https:\/\/doi.org\/10.1016\/s0140-6736(09)61343-x","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1164334.625261","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.1164334.626055","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.1164334.5187055","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.1164334.628456","asserted-by":"object"}]},"ISSN":["0140-6736"],"issn-type":[{"value":"0140-6736","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0140-6736(09)61343-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S0140-6736(09)61464-1","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S0140-6736(09)61468-9","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}